Literature DB >> 12964492

The role of nitric oxide in vascular headache.

Paul-Hugo M van der Kuy1, Joseph J Lohman.   

Abstract

Shortly after the invention of nitroglycerin (NTG), it was noticed that this substance is capable of inducing a violent headache. Only recently, it became known that this was due to the release of nitric oxide (NO) by NTG. As the molecular mechanism of migraine pain remains to be determined, NTG, being pro-drug for NO, has been used to study the aetiology and pathophysiology of migraine. Such studies with NTG- and also histamine-induced headaches, have led to propose that NO may be the causative molecule in migraine pain. The evidence supporting the role of NO in migraine is discussed, e.g. substances capable of inducing experimental vascular headache do so with NO as the common mediator, while drugs with antimigraine activity inhibit NO and the cascade of intracellular reactions triggered by NO. The importance of NO as a potential initiator of the migraine attack opens new directions for the pharmacological treatment of migraine and other vascular headaches.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12964492     DOI: 10.1023/a:1024800512790

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  45 in total

1.  Therapeutic effect of reserpine on migraine syndrome: relationship to blood amine levels.

Authors:  F Fog-Moller; B Bryndum; T Dalsgaard-Nielsen; I K Genefke; G Nattero
Journal:  Headache       Date:  1976-01       Impact factor: 5.887

2.  High prevalence of migraine in a high-altitude population.

Authors:  A Arregui; J Cabrera; F Leon-Velarde; S Paredes; D Viscarra; D Arbaiza
Journal:  Neurology       Date:  1991-10       Impact factor: 9.910

3.  Cluster headache and "dynamite headache": blood flow velocities in the middle cerebral artery.

Authors:  J Hannerz; G Hellström; T Klum; N G Wahlgren
Journal:  Cephalalgia       Date:  1990-02       Impact factor: 6.292

4.  Nitrolglycerin as a provocative agent in cluster headache.

Authors:  K Ekbom
Journal:  Arch Neurol       Date:  1968-11

5.  Nitric oxide: a cytotoxic activated macrophage effector molecule.

Authors:  J B Hibbs; R R Taintor; Z Vavrin; E M Rachlin
Journal:  Biochem Biophys Res Commun       Date:  1988-11-30       Impact factor: 3.575

Review 6.  Investigations into the role of nitric oxide and the large intracranial arteries in migraine headache.

Authors:  L L Thomsen
Journal:  Cephalalgia       Date:  1997-12       Impact factor: 6.292

7.  Histamine-1 receptor blockade does not prevent nitroglycerin induced migraine. Support for the NO-hypothesis of migraine.

Authors:  L H Lassen; L L Thomsen; C Kruuse; H K Iversen; J Olesen
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

8.  Methylene blue inhibits hypoxic cerebral vasodilation in awake sheep.

Authors:  J Iwamoto; M Yoshinaga; S P Yang; E Krasney; J Krasney
Journal:  J Appl Physiol (1985)       Date:  1992-12

9.  Nitric oxide is a mediator of hypoxic coronary vasodilatation. Relation to adenosine and cyclooxygenase-derived metabolites.

Authors:  K H Park; L E Rubin; S S Gross; R Levi
Journal:  Circ Res       Date:  1992-10       Impact factor: 17.367

10.  Absence of vasoactive peptide release from brain to cerebral circulation during onset of migraine with aura.

Authors:  L Friberg; J Olesen; T S Olsen; A Karle; R Ekman; J Fahrenkrug
Journal:  Cephalalgia       Date:  1994-02       Impact factor: 6.292

View more
  9 in total

Review 1.  Headache-type adverse effects of NO donors: vasodilation and beyond.

Authors:  G Bagdy; P Riba; V Kecskeméti; D Chase; G Juhász
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

2.  Pharmacology.

Authors:  Hayrunnisa Bolay; Paul Durham
Journal:  Handb Clin Neurol       Date:  2010

3.  High asymmetric dimethylarginine, symmetric dimethylarginine and L-arginine levels in migraine patients.

Authors:  Aylin Reyhani; Yahya Celik; Hakan Karadag; Ozgur Gunduz; Talip Asil; Necdet Sut
Journal:  Neurol Sci       Date:  2017-04-28       Impact factor: 3.307

4.  Episodic dural stimulation in awake rats: a model for recurrent headache.

Authors:  Michael L Oshinsky; Sumittra Gomonchareonsiri
Journal:  Headache       Date:  2007 Jul-Aug       Impact factor: 5.887

Review 5.  Nitric Oxide as a Target for Phytochemicals in Anti-Neuroinflammatory Prevention Therapy.

Authors:  Lalita Subedi; Bhakta Prasad Gaire; Amna Parveen; Sun-Yeou Kim
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

Review 6.  Antidromic vasodilatation and the migraine mechanism.

Authors:  Pierangelo Geppetti; Eleonora Rossi; Alberto Chiarugi; Silvia Benemei
Journal:  J Headache Pain       Date:  2011-12-27       Impact factor: 7.277

7.  Nitric Oxide as a Unique Bioactive Signaling Messenger in Physiology and Pathophysiology.

Authors:  Narendra Tuteja; Mahesh Chandra; Renu Tuteja; Mithilesh K Misra
Journal:  J Biomed Biotechnol       Date:  2004

Review 8.  A Bidirectional View of Migraine and Diet Relationship.

Authors:  Parisa Gazerani
Journal:  Neuropsychiatr Dis Treat       Date:  2021-02-11       Impact factor: 2.570

Review 9.  The role of nitric oxide in brain disorders: Autism spectrum disorder and other psychiatric, neurological, and neurodegenerative disorders.

Authors:  Manish Kumar Tripathi; Maryam Kartawy; Haitham Amal
Journal:  Redox Biol       Date:  2020-05-15       Impact factor: 11.799

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.